HRP20040573A2 - Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolidines - Google Patents

Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolidines Download PDF

Info

Publication number: HRP20040573A2
Authority: HR; Croatia
Prior art keywords: ylidene; substituted; production; compound; dichlorophenyl
Prior art date: 2001-12-21

Application number

HR20040573A

Other languages

English (en)

Croatian (hr)

Inventor

Uwe Heinelt

Hans-Jochen Lang

Armin Hofmeister

Klaus Wirth

Original Assignee

Aventis Pharma Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-21

Filing date

2002-12-09

Publication date

2004-10-31

2002-12-09 Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh

2004-10-31 Publication of HRP20040573A2 publication Critical patent/HRP20040573A2/hr

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Urology & Nephrology (AREA)
Biomedical Technology (AREA)
Tropical Medicine & Parasitology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Transplantation (AREA)
Diabetes (AREA)
Vascular Medicine (AREA)
Obesity (AREA)
Pulmonology (AREA)
Gastroenterology & Hepatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

HR20040573A 2001-12-21 2002-12-09 Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolidines HRP20040573A2 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10163239A DE10163239A1 (de)	2001-12-21	2001-12-21	Substituierte Imidazolidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie enthaltendes Medikament
PCT/EP2002/013921 WO2003053434A1 (de)	2001-12-21	2002-12-09	Substituierte imidazolidine, verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum sowie enthaltendes medikament

Publications (1)

Publication Number	Publication Date
HRP20040573A2 true HRP20040573A2 (en)	2004-10-31

Family

ID=7710363

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HR20040573A HRP20040573A2 (en)	2001-12-21	2002-12-09	Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolidines

Country Status (27)

Country	Link
EP (1)	EP1461034B1 (sr)
JP (1)	JP4571803B2 (sr)
KR (1)	KR100959031B1 (sr)
CN (1)	CN100339079C (sr)
AR (1)	AR037932A1 (sr)
AT (1)	ATE345797T1 (sr)
AU (1)	AU2002361990B2 (sr)
BR (1)	BR0215154A (sr)
CA (1)	CA2470856A1 (sr)
CO (1)	CO5590925A2 (sr)
DE (2)	DE10163239A1 (sr)
DK (1)	DK1461034T3 (sr)
ES (1)	ES2275945T3 (sr)
HR (1)	HRP20040573A2 (sr)
HU (1)	HUP0600836A2 (sr)
IL (2)	IL162562A0 (sr)
MA (1)	MA27149A1 (sr)
MX (1)	MXPA04005388A (sr)
MY (1)	MY134344A (sr)
NO (1)	NO20043009L (sr)
PE (1)	PE20030741A1 (sr)
PL (1)	PL368940A1 (sr)
RS (1)	RS53204A (sr)
RU (1)	RU2004122415A (sr)
TW (1)	TW200305408A (sr)
WO (1)	WO2003053434A1 (sr)
ZA (1)	ZA200404149B (sr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10323701A1 (de)	2003-05-22	2004-12-23	Aventis Pharma Deutschland Gmbh	Verfahren zur Synthese heterocyclischer Verbindungen
JP4384635B2 (ja)	2003-06-30	2009-12-16	住友化学株式会社	不斉尿素化合物およびこれを触媒として用いる不斉共役付加反応による不斉化合物の製造方法
DE10341240A1 (de) *	2003-09-08	2005-04-07	Aventis Pharma Deutschland Gmbh	Substituierte Thienoimidazole, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
ME03311B (me)	2014-07-25	2019-10-20	Taisho Pharmaceutical Co Ltd	Fenil teтrahidroizokvinolinsko jedinjenje supsтituisano heteroarilom

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3202660A (en) *	1961-10-09	1965-08-24	Boehringer Sohn Ingelheim	Process for the preparation of 3-arylamino-1, 3-diazacycloalkenes
US3236857A (en) *	1961-10-09	1966-02-22	Boehringer Sohn Ingelheim	2-(phenyl-amino)-1, 3-diazacyclopentene-(2) substitution products
EP0070084A3 (en) *	1981-04-24	1983-02-16	Beecham Group Plc	Imidazoline derivatives
DE3712385A1 (de) *	1987-04-11	1988-10-27	Boehringer Ingelheim Kg	2-(phenylimino)imidazolidine
GB9313330D0 (en) *	1993-06-28	1993-08-11	Fujisawa Pharmaceutical Co	New compound and its preparation
EP0639573A1 (de) *	1993-08-03	1995-02-22	Hoechst Aktiengesellschaft	Benzokondensierte 5-Ringheterocyclen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, ihre Verwendung als Diagnostikum, sowie sie enthaltendes Medikament
DE4328869A1 (de) *	1993-08-27	1995-03-02	Hoechst Ag	Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
KR100257129B1 (ko) *	1993-09-11	2000-05-15	성재갑	신규 세팔로스포린계 항생제 및 이의 제조방법
US5552415A (en) *	1993-12-21	1996-09-03	Eli Lilly And Company	Method of inhibiting Alzheimer's Disease
DE19548812A1 (de) *	1995-12-27	1997-07-03	Hoechst Ag	Verwendung von Inhibitoren des zellulären Na·+·/H·+·-Exchangers (NHE) zur Herstellung eines Medikaments zur Atemstimulation
DE19633966A1 (de) *	1996-08-22	1998-02-26	Hoechst Ag	Phenylsubstituierte Alkenylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DK0966465T3 (da) *	1997-03-14	2003-10-20	Vertex Pharma	Inhibitorer af IMPDH-enzymer
DE19945302A1 (de) *	1999-09-22	2001-03-29	Merck Patent Gmbh	Biphenylderivate als NHE-3-Inhibitoren
DE19950898A1 (de) *	1999-10-22	2001-04-26	Aventis Pharma Gmbh	Heterocyclisch substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19960204A1 (de) *	1999-12-14	2001-06-28	Aventis Pharma Gmbh	Substituierte Norlbornylamino-Derivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE10015248A1 (de) *	2000-03-28	2001-10-04	Merck Patent Gmbh	Bisamidino-Verbindungen als NHE-3 Inhibitoren
DE10019062A1 (de) *	2000-04-18	2001-10-25	Merck Patent Gmbh	2-Guanidino-4-aryl-chinazoline als NHE-3 Inhibitoren
DE10060292A1 (de) *	2000-12-05	2002-06-20	Aventis Pharma Gmbh	Verwendung substituierter Benzimidazole zur Herstellung eines Medikaments zur Behandlung von Krankheiten, welche durch Inhibierung des Na+/H+-Austauschers beeinflusst werden können und sie enthaltendes Medikament

2001
- 2001-12-21 DE DE10163239A patent/DE10163239A1/de not_active Withdrawn
2002
- 2002-12-09 PL PL02368940A patent/PL368940A1/xx not_active Application Discontinuation
- 2002-12-09 AT AT02796586T patent/ATE345797T1/de not_active IP Right Cessation
- 2002-12-09 WO PCT/EP2002/013921 patent/WO2003053434A1/de not_active Ceased
- 2002-12-09 ES ES02796586T patent/ES2275945T3/es not_active Expired - Lifetime
- 2002-12-09 CA CA002470856A patent/CA2470856A1/en not_active Abandoned
- 2002-12-09 MX MXPA04005388A patent/MXPA04005388A/es active IP Right Grant
- 2002-12-09 JP JP2003554191A patent/JP4571803B2/ja not_active Expired - Fee Related
- 2002-12-09 RS YU53204A patent/RS53204A/sr unknown
- 2002-12-09 EP EP02796586A patent/EP1461034B1/de not_active Expired - Lifetime
- 2002-12-09 AU AU2002361990A patent/AU2002361990B2/en not_active Ceased
- 2002-12-09 DK DK02796586T patent/DK1461034T3/da active
- 2002-12-09 RU RU2004122415/04A patent/RU2004122415A/ru not_active Application Discontinuation
- 2002-12-09 KR KR1020047009820A patent/KR100959031B1/ko not_active Expired - Fee Related
- 2002-12-09 IL IL16256202A patent/IL162562A0/xx unknown
- 2002-12-09 HU HU0600836A patent/HUP0600836A2/hu unknown
- 2002-12-09 HR HR20040573A patent/HRP20040573A2/hr not_active Application Discontinuation
- 2002-12-09 BR BR0215154-5A patent/BR0215154A/pt not_active IP Right Cessation
- 2002-12-09 DE DE50208809T patent/DE50208809D1/de not_active Expired - Lifetime
- 2002-12-09 CN CNB028258177A patent/CN100339079C/zh not_active Expired - Fee Related
- 2002-12-11 PE PE2002001194A patent/PE20030741A1/es not_active Application Discontinuation
- 2002-12-19 TW TW091136596A patent/TW200305408A/zh unknown
- 2002-12-19 AR ARP020105018A patent/AR037932A1/es unknown
- 2002-12-20 MY MYPI20024821A patent/MY134344A/en unknown
2004
- 2004-05-27 ZA ZA200404149A patent/ZA200404149B/en unknown
- 2004-06-01 MA MA27709A patent/MA27149A1/fr unknown
- 2004-06-16 IL IL162562A patent/IL162562A/en not_active IP Right Cessation
- 2004-06-17 CO CO04056920A patent/CO5590925A2/es not_active Application Discontinuation
- 2004-07-15 NO NO20043009A patent/NO20043009L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
ES2275945T3 (es)	2007-06-16
TW200305408A (en)	2003-11-01
ATE345797T1 (de)	2006-12-15
CN1606440A (zh)	2005-04-13
AU2002361990A1 (en)	2003-07-09
PE20030741A1 (es)	2003-09-29
HUP0600836A2 (en)	2008-04-28
CN100339079C (zh)	2007-09-26
RU2004122415A (ru)	2005-03-27
MA27149A1 (fr)	2005-01-03
KR100959031B1 (ko)	2010-05-20
EP1461034A1 (de)	2004-09-29
AU2002361990B2 (en)	2008-10-09
JP2005516947A (ja)	2005-06-09
DE10163239A1 (de)	2003-07-10
CO5590925A2 (es)	2005-12-30
JP4571803B2 (ja)	2010-10-27
RS53204A (sr)	2006-10-27
CA2470856A1 (en)	2003-07-03
WO2003053434A1 (de)	2003-07-03
NO20043009L (no)	2004-07-15
MXPA04005388A (es)	2004-10-11
IL162562A (en)	2009-12-24
IL162562A0 (en)	2005-11-20
PL368940A1 (en)	2005-04-04
DK1461034T3 (da)	2007-03-26
BR0215154A (pt)	2004-10-19
KR20040068322A (ko)	2004-07-30
MY134344A (en)	2007-12-31
ZA200404149B (en)	2006-05-31
DE50208809D1 (de)	2007-01-04
AR037932A1 (es)	2004-12-22
EP1461034B1 (de)	2006-11-22

Legal Events

Date	Code	Title	Description
2004-10-31	A1OB	Publication of a patent application
2005-04-28	ARAI	Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
2005-11-04	ODRP	Renewal fee for the maintenance of a patent	Payment date: 20051104 Year of fee payment: 4
2006-02-09	PNAN	Change of the applicant name, address/residence	Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH, DE
2008-11-03	OBST	Application withdrawn

Publication	Publication Date	Title
RU2272031C2 (ru)	2006-03-20	Замещенные 2-анилино-бензимидазолы, их применение в качестве ингибиторов na+/h+-обмена, а также содержащее их лекарственное средство
EP1794128B1 (de)	2012-01-11	Substituierte 4-phenyltetrahydroisochinoline, verfahren zu ihrer herstellung, ihre verwendung als medikament, sowie sie enthaltendes medikament
US20080167359A1 (en)	2008-07-10	N-Substituted (Benzoimidazol-2-yl)phenylamines, Processes for Their Preparation, Their Use as a Medicament or Diagnostic Aid, and a Medicament Comprising Them
US20080275098A1 (en)	2008-11-06	Novel substituted 2-aminoimidazoles, process for their preparation, their use as medicament or diagnostic aid
RU2315766C2 (ru)	2008-01-27	Замещенные тиофены, их применение в качестве лекарственного или диагностического средства и содержащее их лекарственное средство
HRP20040573A2 (en)	2004-10-31	Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolidines
US20030187045A1 (en)	2003-10-02	Substituted imidazolidines, process for their preparation, and their use as a medicament or diagnostic
MXPA05007247A (es)	2005-09-08	(benzoimidazol-2-il)fenilaminas n-sustituidas, procedimiento para su preparacion, su uso como medicamento o agente de diagnostico, asi como medicamento que las contienen.